RE:Sweeney & McCaffrey yesterday on CBC Radio! Hello narmac. It seems your interest in RVX is coming back slowly.
On the issue you raised on the "Long Covid", according to Dr. Sweeney in the CBC interview...
"most of the conditions with COVID is due to the body's response to it rather than the virus itself and what apabetalone does is it causes the genes which are responsible for the inflammation to reduce the expression and reduces the inflammation and also reduces the entry of the virus itself. Apabetalone looks at both the viral entry and the body's response to it and hence can be used up to 10 days after the onset of COVID 19 symptoms."... Pfizer's Paxlovid looks at the viral DNA/RNA that prevents the viral replication and has to be used with the very active viral phase of the disease within the first 5 days.
According to Dr. Sweeney also in the CBC interview,
"Part of the exploratory Clinical Programme is to look at whether earlier interventions would prevent Long COVID as well, thus following patients up to six months to make sure they have no symptoms thereafter."
Hoping that should the Trial shows to be positive (and hopefully soon) they will announce it right away and not wait for the aforementioned six months patient follow-up, "Long COVID" results.
Well, the share price is holding pretty steady. It's looking up!
GLTA
G1945V